Inventor · disambiguated record
Andrew Donald Nash
Also filed as: NASH ANDREW · NASH ANDREW D · NASH ANDREW DONALD
29 granted patents·22 pending applications·107 citations·filing 1998–2024
96Inventor score
Top patents by PatentIndex Score
51 records- 0192US8182814B2Methods of treating inflammatory airway conditions by inhibition of IL-11 activityBACA MANUEL·Filed 2008·Granted May 22, 2012·22 cites·16 claims
- 0291US7754213B2High affinity antibody antagonists of interleukin-13 receptor alpha 1MERCK & CO INC·Filed 2007·Granted Jul 13, 2010·13 cites·7 claims
- 0390US9856326B2Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodiesCSL BEHRING GMBH·Filed 2016·Granted Jan 2, 2018·9 cites·23 claims
- 0488US9856325B2Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodiesCSL BEHRING GMBH·Filed 2016·Granted Jan 2, 2018·6 cites·24 claims
- 0587US8535669B2Methods of treating lupus by administering humanized anti-interleukin 3 receptor alpha chain antibodiesVAIRO GINO LUIGI·Filed 2011·Granted Sep 17, 2013·7 cites·17 claims
- 0687US2024124596A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 0786US2025051462A1Antibodies against g-csfr and uses thereofCSL LTD·Filed 2024·Application pending·0 cites
- 0885US9758585B2Compositions and methods for targeting type 1 interferon producing cellsCSL LTD·Filed 2015·Granted Sep 12, 2017·2 cites·16 claims
- 0985US9518127B2Inhibitory anti-factor XII/XIIA monoclonal antibodies and their usesPANOUSIS CON·Filed 2012·Granted Dec 13, 2016·8 cites·22 claims
- 1084US8263075B2Antibody molecule for human GM-CSF receptor alphaCOHEN EMMA SUZANNE·Filed 2007·Granted Sep 11, 2012·6 cites·10 claims
- 1183US8506960B2Antibody molecule for human GM-CSF receptor alphaCOHEN EMMA SUZANNE·Filed 2007·Granted Aug 13, 2013·5 cites·15 claims
- 1282US9193793B2Antibodies against G-CSFR and uses thereofNASH ANDREW DONALD·Filed 2012·Granted Nov 24, 2015·6 cites·21 claims
- 1379US9371388B2High affinity antibody antagonists of interleukin-13 receptor alpha 1CSL LTD·Filed 2013·Granted Jun 21, 2016·2 cites·4 claims
- 1477US9085628B2Antibody molecule for human GM-CSF receptor alphaMEDIMMUNE LTD·Filed 2013·Granted Jul 21, 2015·2 cites·16 claims
- 1576US10513560B2Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodiesCSL BEHRING GMBH·Filed 2017·Granted Dec 24, 2019·1 cites·21 claims
- 1676US9777062B2High affinity antibody antagonists of interleukin-13 receptor alpha 1CSL LTD·Filed 2016·Granted Oct 3, 2017·1 cites·10 claims
- 1776US8568722B2High affinity antibody antagonists of interleukin-13 receptor alpha 1NASH ANDREW DONALD·Filed 2010·Granted Oct 29, 2013·2 cites·2 claims
- 1875US7517524B2Immunointeractive moleculesZENYTH OPERATIONS PTY LTD·Filed 2007·Granted Apr 14, 2009·4 cites·6 claims
- 1974US8207304B2Antibody antagonists of interleukin-13 receptor α1NASH ANDREW DONALD·Filed 2007·Granted Jun 26, 2012·2 cites·6 claims
- 2074US2021147559A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 2171US12071484B2Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded proteinCSL LTD·Filed 2020·Granted Aug 27, 2024·0 cites·14 claims
- 2271US8613925B2Anti-IL-13Rα1 antibodies and their uses thereofNASH ANDREW DONALD·Filed 2007·Granted Dec 24, 2013·1 cites·9 claims
- 2368US8221755B2Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1)DUNLOP FELICITY MEREDITH·Filed 2010·Granted Jul 17, 2012·2 cites·4 claims
- 2468US7785590B2Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1)ZENYTH OPERATIONS PTY LTD·Filed 2004·Granted Aug 31, 2010·3 cites·12 claims
- 2567US11345759B2Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodiesCSL BEHRING GMBH·Filed 2019·Granted May 31, 2022·0 cites·22 claims
- 2667US2019309077A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
- 2767US2014178364A1Compositions and methods for targeting type 1 interferon producing cellsCSL LTD·Filed 2013·Application pending·0 cites
- 2865US7256007B2Methods of regulating cytokine signallingINST MEDICAL W & E HALL·Filed 2001·Granted Aug 14, 2007·2 cites·17 claims
- 2965US2019040145A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2018·Application pending·0 cites
- 3064US10106617B2High affinity antibody antagonists of interleukin-13 receptor alpha 1CSL LTD·Filed 2017·Granted Oct 23, 2018·0 cites·12 claims
- 3163US2019055313A1Antibodies against g-csfr and uses thereofCSL LTD·Filed 2018·Application pending·0 cites
- 3262US7192576B1Biologically active complex of NR6 and cardiotrophin-like-cytokineZENYTH OPERATIONS PTY LTD·Filed 2000·Granted Mar 20, 2007·1 cites·6 claims
- 3359US2017226214A1Antibodies against g-csfr and uses thereofCSL LTD·Filed 2017·Application pending·0 cites
- 3457US2015376285A1Antibody Molecule For Human GM-CSF Receptor AlphaMEDIMMUNE LTD·Filed 2015·Application pending·0 cites
- 3555US2016031998A1Antibodies against g-csfr and uses thereofCSL LTD·Filed 2015·Application pending·0 cites
- 3655US2009285831A1Immunointeractive moleculesZENYTH OPERATIONS PTY LTD·Filed 2009·Application pending·0 cites
- 3754US2008057517A1Methods of regulating cytokine signallingWALTER AND ELIZA INST OF MEDIC·Filed 2007·Application pending·0 cites
- 3850US9376682B2Method of treating pulmonary disease by administering an antibody to G-CSFCSL LTD·Filed 2013·Granted Jun 28, 2016·0 cites·7 claims
- 3949US2006294608A1Novel haemopoietin receptor and genetic sequences encoding sameZENYTH OPERATIONS PTY LTD·Filed 2006·Application pending·0 cites
- 4049US2014363445A1Method of treating cancer comprising a vegf-b antagonistZENYTH OPERATIONS PTY LTD·Filed 2014·Application pending·0 cites
- 4149US2008009447A1Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of SOCS sequence in the animalAMRAD OPERATIONS PTY LTD·Filed 2007·Application pending·0 cites
- 4246US8574572B2Method of treating pulmonary disease by administering an antibody to G-CSF receptorCRUMP DAVID ERIC·Filed 2007·Granted Nov 5, 2013·0 cites·8 claims
- 4345US8822644B2Method of treating cancer comprising a VEGF-B antagonistNASH ANDREW·Filed 2005·Granted Sep 2, 2014·0 cites·29 claims
- 4444US2004005671A1Immunointeractive moleculesAMRAD OPERATIONS PTY LTD·Filed 2003·Application pending·0 cites
- 4541US2007111944A1Purification of vascular endothelial growth factor-BSCROFANI SERGIO D B·Filed 2006·Application pending·0 cites
- 4639US2006057665A1Galectin-14 therapeutic molecule and uses thereofUNIV MELBOURNE·Filed 2002·Application pending·0 cites
- 4739US2004137588A1Purification of vascular endothelial growth factor-bSCROFANI SERGIO D B·Filed 2001·Application pending·0 cites
- 4839US2008009444A1Biologically active complex of NR6 and cardiotrophin-like-cytokineZENYTH OPERATIONS PTY LTD·Filed 2007·Application pending·0 cites
- 4938US2004072752A1Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animalFiled 2001·Application pending·0 cites
- 5037US2011217366A1Immunopotentiating compositionDAINIPPON SUMITOMO PHARMA CO·Filed 2011·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →